Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
3.34M
-
Shares change
-
+170K
-
Total reported value, excl. options
-
$10.4M
-
Value change
-
+$297K
-
Number of buys
-
10
-
Number of sells
-
-12
-
Price
-
$3.11
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q1 2020
38 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q1 2020.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.34M shares
of 104M outstanding shares and own 3.22% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1.85M shares), VANGUARD GROUP INC (321K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (224K shares), MORGAN STANLEY (221K shares), GEODE CAPITAL MANAGEMENT, LLC (205K shares), MILLENNIUM MANAGEMENT LLC (146K shares), Advisor Group Holdings, Inc. (56.3K shares), GOLDMAN SACHS GROUP INC (53.6K shares), NORTHERN TRUST CORP (48.9K shares), and JANE STREET GROUP, LLC (30.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.